pancreatitis%20-%20chronic
PANCREATITIS - CHRONIC
Chronic pancreatitis develops from irreversible scarring sustained by the pancreas from prolonged inflammation.
Signs and symptoms include abdominal pain that is epigastric in location that radiates to the back and frequently occurs at night or after meals, symptoms of fat, protein & carbohydrates maldigestion that become apparent with advanced chronic pancreatitis and presence of diarrhea.
Chronic pancreatitis results in destruction of alpha and beta cells which gives rise to deficiencies of both insulin and glucagon.

Treatment of Complications

  • Complications of chronic pancreatitis result from exocrine & endocrine insufficiency

Diabetes Mellitus (DM)

  • Diabetes results from destruction of pancreatic acinar cells
    • Insulin secretion is not completely lost while glucagon secretion is reduced
  • Treatment is often directed at controlling urinary glucose losses rather than blood sugar levels
    • Avoid tight control of glucose levels as treatment-induced hypoglycemia can be fatal especially in malnourished patients
  • Insulin is usually required, but some patients may still respond to oral antidiabetic agents
  • Monitor patients for complications of long-standing diabetes (eg nephropathy, neuropathy & retinopathy)

Maldigestion

  • Advise patients to follow a low-fat diet
  • Enzyme supplementation w/ lipase during & after a meal may reduce steatorrhea
  • Supplementation w/ fat-soluble vitamins (eg vitamin D) is beneficial & MCTs can help prevent weight loss
  • Response to treatment may be measured through loss of visible stool fat, improved stool consistency, weight gain & normalization of fat-soluble vitamin levels

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 Apr 2019
Cannabis use disorder appears to exert a beneficial effect on the risk of disorders of gut–brain interaction and inflammatory bowel disease in patients with schizophrenia but not in population controls, a study has found. This finding raises the possibility of new targets for treatment and prevention of digestive organ disorders in schizophrenia.
10 Apr 2019
An individualized, food-based diet may be a potential treatment approach for patients with active Crohn’s disease, successfully replicating microbiome changes elicited by exclusive enteral nutrition and reducing gut inflammation, a recent study has shown.
12 Nov 2018
Individuals with severe and frequent gastro-oesophageal reflux disease (GERD) are at increased risk of Barrett’s oesophagus (BE), especially in the absence of frequent proton pump inhibitor (PPI) use, a recent study has found. Family history of BE and early age of symptom onset are strong predictors of BE among people with GERD.